IDM-4

IDM-4 Uses, Dosage, Side Effects, Food Interaction and all others data.

IDM-4 is an immuno-designed molecule that completed phase I/II of investigation for the treatment of Leukemia. It is a monoclonal antibody-specific antigen that can selectively target cancer-affected cells by coupling with tumor cell-killing MAK cells, which are derived from the patient's own monocytes. Trials of this drug have most likely been discontinued by the manufacturer.

This monoclonal antibody-specific antigen selectively targets cancer-affected cells by coupling with tumor cell-killing MAK cells, which are derived from the patient's own monocytes.

Table Of contents

• IDM-4
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	IDM-4
Generic	IDM-4
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in leukemia (lymphoid).

How IDM-4 works

The lipid promotes fusion of liposomes to cells. Specifically, IDM-4 targets tumor cells by coupling MAK cells with tumor antigens obtained from the patient.

Toxicity

Toxicity is reported to be low for various Monoclonal antibodies.

Innovators Monograph

You find simplified version here IDM-4